Placebo analgesia: Cognitive influences on therapeutic outcome

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Watson, Alison ^a   Power, Andrea ^a   Brown, Christopher ^a   El Deredy, Wael ^a   Jones, Anthony ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; SEROTONIN; SEROTONIN TRANSPORTER;

ACUPUNCTURE; ALLELE; AMYGDALOID NUCLEUS; ANALGESIA; ANTERIOR CINGULATE; ANXIETY; BEHAVIOR; CINGULATE GYRUS; CLINICAL TRIAL (TOPIC); COPING BEHAVIOR; DIENCEPHALON; DOCTOR PATIENT RELATION; DRUG EFFICACY; EXPECTATION; EXPERIENCE; GROUPS BY AGE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD; NEUROBIOLOGY; NEUROPSYCHOLOGY; NEUROSIS; NEUROTRANSMISSION; OPTIMISM; OUTCOME ASSESSMENT; PERIAQUEDUCTAL GRAY MATTER; PESSIMISM; PLACEBO EFFECT; POLYPHARMACY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SOCIAL ASPECT; SPINAL CORD; SPINAL CORD DORSAL HORN;

EID: 84859432586     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3783     Document Type: Review

References (54)

1. Benedetti F. How the doctor's words affect the patient's brain. Eval Health Prof 2002, 25:369-386. 10.1177/0163278702238051, 12449081.
2. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010, 375:686-695. 10.1016/S0140-6736(09)61706-2, 2832199, 20171404.
3. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010, 5:e15591. 10.1371/journal.pone.0015591, 3008733, 21203519.
4. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA 2012, 307:567-568. 10.1001/jama.2012.115, 22318275.
5. Bingel U, Colloca L, Vase L. Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology 2011, 57:354-363. 10.1159/000322090, 20975261.
6. Kienle GS, Kiene H. Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Altern Ther Health Med 1996, 2:39-54.
7. Aslaksen PM, Bystad M, Vambheim SM, Flaten MA. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom Med 2011, 73:193-199. 10.1097/PSY.0b013e3182080d73, 21217098.
8. Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004, 130:324-340.
9. Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatry 2011, 24:149-155. 10.1097/YCO.0b013e328343803b, 21248640.
10. Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain 2005, 117:450-461. 10.1016/j.pain.2005.08.006, 16154274.
11. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011, 3:70ra14. 10.1126/scitranslmed.3001244, 21325618.
12. Geers AL, Wellman JA, Fowler SL, Helfer SG, France CR. Dispositional optimism predicts placebo analgesia. J Pain 2010, 11:1165-1171. 10.1016/j.jpain.2010.02.014, 2956003, 20627818.
13. Geers AL, Weiland PE, Kosbab K, Landry SJ, Helfer SG. Goal activation, expectations, and the placebo effect. J Pers Soc Psychol 2005, 89:143-159.
14. Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res 2005, 58:121-127. 10.1016/j.jpsychores.2004.08.011, 15820839.
15. Morton DL, El-Deredy W, Watson A, Jones AK. Placebo analgesia as a case of a cognitive style driven by prior expectation. Brain Res 2010, 1359:137-141.
16. Morton DL, Brown CA, Watson A, El-Deredy W, Jones AK. Cognitive changes as a result of a single exposure to placebo. Neuropsychologia 2010, 48:1958-1964. 10.1016/j.neuropsychologia.2010.03.016, 20331992.
17. Morton DL, Watson A, El-Deredy W, Jones AK. Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain 2009, 146:194-198. 10.1016/j.pain.2009.07.026, 19692178.
18. Segerstrom S. Optimism, goal conflict, and stressor-related immune change. J Behav Med 2001, 24:441-467. 10.1023/A:1012271410485, 11702359.
19. Park CL, Moore PJ, Turner RA, Adler NE. The roles of constructive thinking and optimism in psychological and behavioral adjustment during pregnancy. J Pers Soc Psychol 1997, 73:584-592.
20. Scheier MF, Carver CS. Effects of optimism on psychological and physical well-being: theoretical overview and empirical update. Cognit Ther Res 1992, 16:201-228.
21. Geers AL, Handley IM, McLarney AR. Discerning the role of optimism in persuasion: the valence-enhancement hypothesis. J Pers Soc Psychol 2003, 85:554-565.
22. Tremblay I, Sullivan MJ. Attachment and pain outcomes in adolescents: the mediating role of pain catastrophizing and anxiety. J Pain 2010, 11:160-171. 10.1016/j.jpain.2009.06.015, 19853522.
23. Tang J, Gibson SJ. A psychophysical evaluation of the relationship between trait anxiety, pain perception, and induced state anxiety. J Pain 2005, 6:612-619. 10.1016/j.jpain.2005.03.009, 16139780.
24. Carlino E, Pollo A, Benedetti F. Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience. Curr Opin Anaesthesiol 2011, 24:540-544. 10.1097/ACO.0b013e328349d0c2, 21772145.
25. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005, 115:338-347. 10.1016/j.pain.2005.03.014, 15911161.
26. McCracken LM, Keogh E. Acceptance, mindfulness, and values-based action may counteract fear and avoidance of emotions in chronic pain: an analysis of anxiety sensitivity. J Pain 2009, 10:408-415. 10.1016/j.jpain.2008.09.015, 19327643.
27. Evans FJ. The placebo response in pain reduction. Adv Neurol 1974, 4:289-300.
28. Benedetti F, Carlino E, Pollo A. How placebos change the patient's brain. Neuropsychopharmacology 2011, 36:339-354. 10.1038/npp.2010.81, 3055515, 20592717.
29. Hojat M, Spandorfer J, Louis DZ, Gonnella JS. Empathic and sympathetic orientations toward patient care: conceptualization, measurement, and psychometrics. Acad Med 2011, 86:989-995. 10.1097/ACM.0b013e31822203d8, 21694570.
30. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain 2001, 93:77-84. 10.1016/S0304-3959(01)00296-2, 11406341.
31. Fields HL. Understanding how opioids contribute to reward and analgesia. Reg Anesth Pain Med 2007, 32:242-246.
32. Bingel U. Mechanisms of endogenous pain modulation illustrated by placebo analgesia: functional imaging findings [in German]. Schmerz 2010, 24:122-129. 10.1007/s00482-010-0901-7, 20376600.
33. Millan MJ. Descending control of pain. Prog Neurobiol 2002, 66:355-474. 10.1016/S0301-0082(02)00009-6, 12034378.
34. Rivot JP, Weilfugazza J, Godefroy F, Bineauthurotte M, Orylavollee L, Besson JM. Involvement of serotonin in both morphine and stimulation-produced analgesia - electrochemical and biochemical approaches. Advances in Pain Research and Therapy. Neural Mechanisms of Pain 1984, 6:135-150. New York: Raven Press, Kruger L, Liebeskind JC.
35. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984, 7:309-338. 10.1146/annurev.ne.07.030184.001521, 6143527.
36. Bodnar RJ, Klein GE. Endogenous opiates and behavior: 2005. Peptides 2006, 27:3391-3478. 10.1016/j.peptides.2006.07.011, 16973239.
37. Sauro MD, Greenberg RP. Endogenous opiates and the placebo effect: a meta-analytic review. J Psychosom Res 2005, 58:115-120. 10.1016/j.jpsychores.2004.07.001, 15820838.
38. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 2007, 104:11056-11061. 10.1073/pnas.0702413104, 1894566, 17578917.
39. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci 2009, 1156:198-210. 10.1111/j.1749-6632.2009.04424.x, 3073412, 19338509.
40. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009, 63:533-543. 10.1016/j.neuron.2009.07.014, 19709634.
41. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS. Placebo effects mediated by endogenous opioid activity on {micro}-opioid receptors. J Neurosci 2005, 25:7754-7762. 10.1523/JNEUROSCI.0439-05.2005, 16120776.
42. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004, 303:1162-1167. 10.1126/science.1093065, 14976306.
43. Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. Pain 2010, 151:816-824. 10.1016/j.pain.2010.09.021, 20943318.
44. Watson A, El-Deredy W, Iannetti GD, Lloyd D, Tracey I, Vogt BA, Nadeau V, Jones AK. Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception. Pain 2009, 145:24-30. 10.1016/j.pain.2009.04.003, 2743811, 19523766.
45. Melke J, Landén M, Baghei F, Rosmond R, Holm G, Björntorp P, Westberg L, Hellstrand M, Eriksson E. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet 2001, 105:458-463. 10.1002/ajmg.1434, 11449399.
46. Du L, Bakish D, Hrdina PD. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet 2000, 10:159-164. 10.1097/00041444-200010040-00002, 11324940.
47. Lesch KP, Mossner R. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handb Exp Pharmacol 2006, (175):417-456.
48. Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, Långström B, Eriksson E, Fredrikson M. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008, 28:13066-13074. 10.1523/JNEUROSCI.2534-08.2008, 19052197.
49. Preuss D, Schoofs D, Schlotz W, Wolf OT. The stressed student: influence of written examinations and oral presentations on salivary cortisol concentrations in university students. Stress 2010, 13:221-229. 10.3109/10253890903277579, 20235829.
50. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006, 26:12014-12022. 10.1523/JNEUROSCI.2947-06.2006, 17108175.
51. Cherniack EP. Would the elderly be better off if they were given more placebos?. Geriatr Gerontol Int 2010, 10:131-137.
52. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 2011, 59:1477-1483. 10.1111/j.1532-5415.2011.03491.x, 21707557.
53. Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: a meta-analysis of antidepressent medication. Prevention & Treatment 1998, 1:Article 0002a. 3311636, 22457830.
54. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002, 159:728-737. 10.1176/appi.ajp.159.5.728, 11986125.